Publication date: Available online 31 October 2015
Source:Vaccine
Author(s): Allen C. Cheng, Tom Kotsimbos, Paul M. Kelly
We provide estimates of the influenza vaccine protection against hospitalisation with laboratory-confirmed influenza in the 2014 Australian season where the A/H1N1/pdm09 strain predominated. This was performed using a case-test negative study design as part of a national sentinel surveillance system in Australia. Vaccine effectiveness was estimated as (1-OR)×100% where the odds ratio of vaccination in cases vs test negative participants was estimated from a conditional logistic regression. Between April and November, 1692 adult patients were admitted with laboratory-confirmed influenza. Vaccine effectiveness was estimated from 1283 patients with influenza and 1116 test negative patients where vaccination status was ascertained. Vaccination was associated with a reduction in the risk of hospitalisation with influenza of 51.5% (95% CI: 41.6%, 59.7%) in all patients, and a reduction of 50.7% (95% CI: 40.1%, 59.3%) in the target population for vaccination. We estimate that the influenza vaccine was moderately protective against hospitalisation with laboratory-confirmed influenza during the 2014 influenza season in Australia.
from #Medicine via ola Kala on Inoreader http://ift.tt/1Q2PzGr
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
-
▼
2015
(2119)
- ► Δεκεμβρίου (940)
-
▼
Οκτωβρίου
(414)
-
▼
Οκτ 31
(22)
- Influenza vaccine effectiveness against hospitalis...
- A new EV71 VP3 epitope in norovirus P particle vec...
- Pros and cons of VP1-specific maternal IgG for the...
- Differences in efficiency, satisfaction and advers...
- Pertussis vaccination during pregnancy in Vietnam:...
- PneuMum: Impact from a randomised controlled trial...
- Translating Research to Practice for Children With...
- Testing anti-HIV activity of antiretroviral agents...
- Risk of congenital cytomegalovirus infection among...
- Susceptibility of HPV16 and 18 to high level disin...
- Increased expression and dysregulated association ...
- Human papillomavirus infection in male patients wi...
- Hydrolyzed fish proteins reduced activation of cas...
- Contaminant release history identification in 2-D ...
- Medicine,New Articles,October 31st,2015
- Synthesis and comparison of the biological activit...
- 1,2,3-Triazole pharmacophore-based benzofused nitr...
- Discovery of bis-ary urea derivatives as potent an...
- Synthesis of di- and tri-saccharide fragments of S...
- Investigation of the mechanisms of Angelica dahuri...
- Retrospective case-series of Paecilomyces lilacinu...
- Meningitis caused by Pasteurella multocida in a do...
-
▼
Οκτ 31
(22)
Αναζήτηση αυτού του ιστολογίου
Σάββατο 31 Οκτωβρίου 2015
Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.